1468 related items for PubMed ID: 18829172
1. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[Abstract] [Full Text] [Related]
2. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[Abstract] [Full Text] [Related]
3. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, Dose T, Wollweber B, Spieler D, Messer T, Lutz R, Künzel H, Bierner T, Pollmächer T, Pfister H, Nickel T, Sonntag A, Uhr M, Ising M, Holsboer F, Lucae S.
J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
[Abstract] [Full Text] [Related]
4. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[Abstract] [Full Text] [Related]
5. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
[Abstract] [Full Text] [Related]
6. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
Neuropsychopharmacology; 2003 Dec 01; 28(12):2169-78. PubMed ID: 12931142
[Abstract] [Full Text] [Related]
7. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
Psychoneuroendocrinology; 2008 Apr 01; 33(3):313-20. PubMed ID: 18215470
[Abstract] [Full Text] [Related]
8. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
[Abstract] [Full Text] [Related]
9. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
Psychoneuroendocrinology; 2004 Oct 15; 29(9):1101-8. PubMed ID: 15219633
[Abstract] [Full Text] [Related]
10. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB.
Biol Psychiatry; 2005 Feb 15; 57(4):336-42. PubMed ID: 15705348
[Abstract] [Full Text] [Related]
11. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
J Psychiatr Res; 2009 Apr 15; 43(7):702-10. PubMed ID: 19038406
[Abstract] [Full Text] [Related]
12. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
Haefner S, Baghai TC, Schule C, Eser D, Spraul M, Zill P, Rupprecht R, Bondy B.
Neuropsychobiology; 2008 Apr 15; 58(3-4):154-62. PubMed ID: 19088492
[Abstract] [Full Text] [Related]
13. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
Psychoneuroendocrinology; 2010 May 15; 35(4):536-43. PubMed ID: 19818562
[Abstract] [Full Text] [Related]
14. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M.
Biol Psychiatry; 2007 Sep 01; 62(5):400-6. PubMed ID: 17188252
[Abstract] [Full Text] [Related]
15. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M.
J Affect Disord; 2005 Aug 01; 87(2-3):305-11. PubMed ID: 15951024
[Abstract] [Full Text] [Related]
16. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C.
J Neuroendocrinol; 2007 Mar 01; 19(3):213-26. PubMed ID: 17280595
[Abstract] [Full Text] [Related]
17. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728
[Abstract] [Full Text] [Related]
18. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
Neuropsychopharmacology; 2006 Jan 01; 31(1):212-20. PubMed ID: 16123748
[Abstract] [Full Text] [Related]
19. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
Neuropsychobiology; 2007 Jan 01; 55(1):28-35. PubMed ID: 17556850
[Abstract] [Full Text] [Related]
20. The impact of treatment on HPA axis activity in unipolar major depression.
McKay MS, Zakzanis KK.
J Psychiatr Res; 2010 Feb 01; 44(3):183-92. PubMed ID: 19747693
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
